Antiretroviral therapy uses combinations of medicines that target different stages of the HIV replication cycle. HIV depends on several viral enzymes and cellular processes to produce new copies of . . .
HIV is a virus that targets cells involved in coordinating the immune response. After entering a susceptible cell, the virus uses cellular processes to produce genetic . . .
Reverse transcriptase is a viral enzyme with a central role in converting RNA-based genetic information into DNA. HIV carries its genetic information as RNA, while the infected host . . .
The resources needed to treat HIV generally begin with access to appropriate healthcare and an accurate understanding of an individual's health status. HIV care is typically coordinated through . . .
HIV is a virus that attacks cells involved in the immune system. Without effective treatment, HIV can continue multiplying and gradually weaken immune function. Antiretroviral treatment uses combinations of . . .
HIV inhibitors are medicines designed to interfere with specific steps that HIV needs to reproduce inside the body. HIV attacks immune cells, particularly CD4 cells, and uses them to . . .
HIV treatment uses antiretroviral medicines to prevent the virus from multiplying and to help maintain the immune system. Different inhibitor classes act on specific stages of the HIV life . . .
Antiretroviral therapy uses medicines that target HIV at different stages of its life cycle. Rather than relying on one medicine, treatment commonly involves combinations of antiretroviral drugs from different . . .
HIV is a virus that targets the immune system and uses cells in the body to make new copies of itself. Without treatment, ongoing viral replication can gradually weaken . . .
HIV needs several steps to enter human cells, copy its genetic material, and produce new virus particles. HIV inhibitors are antiretroviral medicines designed to interrupt one or more of . . .